SCHEMBL12768063

SCHEMBL12768063

O=C(Oc1ccc2c(c1)C1C=CCC1C(C(=O)O)N2)c1ccc(Cl)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 15/20 1.00
▸ CDC25B P30305 2/20 0.70
▸ HSPA1A P0DMV8 13/20 0.63
▸ MCL1 Q07820 3/20 0.63
▸ BCL2L1 Q07817 1/20 0.63
▸ GAPDH P04406 9/20 0.62
▸ HSPA8 P11142 4/20 0.62
▸ POLB P06746 6/20 0.55
▸ KMT2A Q03164 6/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ BLM P54132 5/20 0.55
▸ L3MBTL1 Q9Y468 5/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ TDP1 Q9NUW8 4/20 0.55
▸ MAPT P10636 3/20 0.55
▸ HPGD P15428 3/20 0.55
▸ ALOX15 P16050 3/20 0.55
▸ BRCA1 P38398 3/20 0.55
▸ RECQL P46063 3/20 0.55
▸ HSD17B10 Q99714 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16883499 0.91 PTPN7 (0.83) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL3610631 0.83 CDC25B (1.00) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL16872914 0.82 PTPN7 (0.69) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL5997359 0.77 PTPN7 (1.00) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL2116204 0.76 PTPN7 (0.85) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL13726154 0.75 PTPN7 (0.81) PTPN7CDC25BHSPA1AMCL1GAPDH
SCHEMBL13725206 0.73 PTPN7 (0.87) PTPN7CDC25BHSPA1AMCL1GAPDH
SCHEMBL13725695 0.73 PTPN7 (0.74) PTPN7CDC25BHSPA1AMCL1GAPDH
SCHEMBL13724862 0.72 PTPN7 (0.76) PTPN7CDC25BHSPA1AMCL1BCL2L1
SCHEMBL2808722 0.72 PTPN7 (1.00) PTPN7CDC25BHSPA1AMCL1GAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA INC (US) 2017-12-07 — — US disclosed
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA INC (US) 2017-12-07 — — US disclosed
US-9775835-B2 Small molecule inhibitors of viral protein interactions with human t-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2017-10-03 — — US disclosed
US-9775835-B2 Small molecule inhibitors of viral protein interactions with human t-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2017-10-03 — — US disclosed
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2015-07-09 — — US disclosed
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2015-07-09 — — US disclosed
US-8962244-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2015-02-24 — — US disclosed
US-8962244-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2015-02-24 — — US disclosed
WO-2014025749-A2 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2014-02-13 — — WO disclosed
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2013-08-22 — — US disclosed
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2013-08-22 — — US disclosed
US-8377639-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2013-02-19 — — US disclosed
US-8377639-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2013-02-19 — — US disclosed
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-17 — — US disclosed
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-03-17 — — US disclosed
WO-2010151797-A2 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2010-12-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 PTPN7 4465/4885CDC25B 3647/4885HSPA1A 2415/4885
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA NSUN3, TARBP1, TRDMT1 PTPN7 2917/4885CDC25B 3421/4885HSPA1A 2079/4885
US-20110065704-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 PTPN7 4465/4885CDC25B 3647/4885HSPA1A 2415/4885
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA NSUN3, TARBP1, TRDMT1 PTPN7 2873/4885CDC25B 3506/4885HSPA1A 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback